Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Aledort

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Journal of Thrombosis and Haemostasis : JTH|October 1, 2004
Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activityL M Aledort
Journal of Thrombosis and Haemostasis : JTH|July 15, 2006
MedWatch: an important instrument for postlicensing surveillanceL M Aledort
Thrombosis and Haemostasis|July 1, 1997
von Willebrand disease: from the bedside to therapyL M Aledort
Seminars in Hematology|July 1, 1991
A safe approach to treatment of factor IX-deficient patients. Introduction and overview of treatmentL M Aledort
Hospital Practice (Office Ed.)|February 15, 1989
New approaches to management of bleeding disordersL M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2016
The evolution of comprehensive haemophilia care in the United States: perspectives from the frontlineL M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Chairman's IntroductionL M Aledort
Vox Sanguinis|January 1, 1996
Inhibitors to coagulation: can we afford immune tolerance induction regimens?L M Aledort
Haemostasis|January 1, 1992
Arthropathy and substitution therapyL M Aledort
Scandinavian Journal of Haematology. Supplementum|January 1, 1984
Side effects of substitution therapyL M Aledort
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Journal of Thrombosis and Haemostasis : JTH|October 1, 2004
Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activityL M Aledort
Journal of Thrombosis and Haemostasis : JTH|July 15, 2006
MedWatch: an important instrument for postlicensing surveillanceL M Aledort
Thrombosis and Haemostasis|July 1, 1997
von Willebrand disease: from the bedside to therapyL M Aledort
Seminars in Hematology|July 1, 1991
A safe approach to treatment of factor IX-deficient patients. Introduction and overview of treatmentL M Aledort
Hospital Practice (Office Ed.)|February 15, 1989
New approaches to management of bleeding disordersL M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2016
The evolution of comprehensive haemophilia care in the United States: perspectives from the frontlineL M Aledort
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Chairman's IntroductionL M Aledort
Vox Sanguinis|January 1, 1996
Inhibitors to coagulation: can we afford immune tolerance induction regimens?L M Aledort
Haemostasis|January 1, 1992
Arthropathy and substitution therapyL M Aledort
Scandinavian Journal of Haematology. Supplementum|January 1, 1984
Side effects of substitution therapyL M Aledort
Pageof 19